We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MOLN icon
51
Molecular Partners
MOLN
$137M
$137M $3.58 1.42%
SPRB icon
52
Spruce Biosciences
SPRB
$133M
$133M $46.39 0.92%
KZIA icon
53
Kazia Therapeutics
KZIA
$132M
$132M $8.50 2.52%
CDXS icon
54
Codexis
CDXS
$130M
$130M $1.19 2.46%
CHRS icon
55
Coherus Oncology
CHRS
$128M
$128M $0.8301 7.6%
FHTX icon
56
Foghorn Therapeutics
FHTX
$124M
$124M $2.08 0.48%
HURA icon
57
TuHURA Biosciences
HURA
$123M
$123M $1.93 6.31%
HUMA icon
58
Humacyte
HUMA
$114M
$114M $0.4112 12.5%
OTLK icon
59
Outlook Therapeutics
OTLK
$114M
$114M $0.4681 5.15%
NKTX icon
60
Nkarta
NKTX
$112M
$112M $1.56 6.02%
NERV icon
61
Minerva Neurosciences
NERV
$111M
$111M $2.32 3.57%
AVXL icon
62
Anavex Life Sciences
AVXL
$110M
$110M $1.19 8.46%
PYPD icon
63
PolyPid
PYPD
$109M
$109M $5.39 3.58%
CLLS icon
64
Cellectis
CLLS
$109M
$109M $1.08 7.69%
ANIX icon
65
Anixa Biosciences
ANIX
$108M
$108M $3.12 5.45%
EQ icon
66
Equillium
EQ
$107M
$107M $1.37 3.52%
OKUR icon
67
OnKure Therapeutics
OKUR
$106M
$106M $2.62 0%
VYGR icon
68
Voyager Therapeutics
VYGR
$106M
$106M $1.72 2.27%
PDSB icon
69
PDS Biotechnology
PDSB
$104M
$104M $1.44 7.1%
UNCY icon
70
Unicycive Therapeutics
UNCY
$104M
$104M $3.74 1.84%
ENGN icon
71
enGene Therapeutics
ENGN
$103M
$103M $1.53 0%
IMUX icon
72
Immunic
IMUX
$102M
$102M $7.51 3.72%
BDTX icon
73
Black Diamond Therapeutics
BDTX
$102M
$102M $1.78 4.3%
TLSA icon
74
Tiziana Life Sciences
TLSA
$102M
$102M $0.8000 11.6%
VTVT icon
75
vTv Therapeutics
VTVT
$100M
$100M $25.17 4.59%
1 2
3
4 5

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 292 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $18.5B.

The largest by market cap are Fate Therapeutics (FATE) at $249M, Abeona Therapeutics (ABEO) at $249M and CAMP4 Therapeutics (CAMP) at $249M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.